YD Bio (YDESW) Receivables - Net (2024 - 2026)
YD Bio's (YDESW) quarterly Receivables - Net came in at $234086.0 in Q2 2026, up 130.79% year-over-year from $101430.0 in Q2 2025, and up 34.47% quarter-over-quarter from $174075.0 in Q4 2025.
Analysis
YD Bio (YDESW) Receivables - Net (2024 - 2026) Analysis & Trends
YD Bio (YDESW) has reported Receivables - Net for 3 consecutive years, with $234086.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Receivables - Net rose 130.79% year-over-year to $234086.0 in Q2 2026; TTM through Jun 2026 was $234086.0, a 130.79% increase from a year earlier, with the FY2025 full-year figure at $174075.0, up 94.2% from the prior year.
- Receivables - Net was $234086.0 for Q2 2026 at YD Bio, up from $174075.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $234086.0 in Q2 2026 and troughed at $86582.0 in Q4 2024.
- A 3-year average of $149043.2 and a median of $137752.5 in 2025 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net soared 101.05% in 2025 and soared 130.79% in 2026, its largest moves.
- Over 3 years, Receivables - Net stood at $86582.0 in 2024, then soared by 101.05% to $174075.0 in 2025, then soared by 34.47% to $234086.0 in 2026.
- The last three Receivables - Net figures came in at $234086.0 (Q2 2026), $174075.0 (Q4 2025), and $101430.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.05 Bn | 198.06 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.76 Bn | 178.58 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.46 Bn | 124.61 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.37 Bn | 1.37 Bn |
| 6 | Moderna | 54.69 Bn | 49.56 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn |
| 8 | Biogen | 31.46 Bn | 30.17 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.15 Bn | 30.15 Bn | 1.16 Mn |
| 10 | YD Bio | 29.02 Mn | 26.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 234,086.00 |
| Dec 31, 2025 | 174,075.00 |
| Jun 30, 2025 | 101,430.00 |
| Dec 31, 2024 | 86,582.00 |